vs
FIRST CAPITAL INC（FCAP）与礼来（RNA）财务数据对比。点击上方公司名可切换其他公司
FIRST CAPITAL INC的季度营收约是礼来的1.1倍（$13.5M vs $12.5M），FIRST CAPITAL INC净利率更高（36.2% vs -1398.3%，领先1434.5%），礼来同比增速更快（434.0% vs 19.0%），FIRST CAPITAL INC自由现金流更多（$19.9M vs $-156.9M），过去两年礼来的营收复合增速更高（138.5% vs 13.4%）
First Capital曾用名Future Capital Holdings，是印度一家非银行金融机构，主营债务融资业务。2018年12月，该机构与IDFC银行合并，组建IDFC第一银行，合并前其股票在印度国家证券交易所和孟买证券交易所挂牌上市。
礼来是总部位于美国印第安纳州印第安纳波利斯的跨国制药企业，在18个国家设有办事处，产品销往全球约125个国家。公司由美国内战时期联邦军退伍军人、药剂师伊莱·礼来于1876年创立，品牌名即取自创始人姓名。
FCAP vs RNA — 直观对比
营收规模更大
FCAP
是对方的1.1倍
$12.5M
营收增速更快
RNA
高出415.1%
19.0%
净利率更高
FCAP
高出1434.5%
-1398.3%
自由现金流更多
FCAP
多$176.8M
$-156.9M
两年增速更快
RNA
近两年复合增速
13.4%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.5M | $12.5M |
| 净利润 | $4.9M | $-174.4M |
| 毛利率 | — | — |
| 营业利润率 | — | -1513.5% |
| 净利率 | 36.2% | -1398.3% |
| 营收同比 | 19.0% | 434.0% |
| 净利润同比 | 49.6% | -117.0% |
| 每股收益（稀释后） | $1.45 | $-1.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FCAPRNA
| Q4 25 | $13.5M | — | ||
| Q3 25 | $13.3M | $12.5M | ||
| Q2 25 | $12.4M | $3.8M | ||
| Q1 25 | $11.4M | $1.6M | ||
| Q4 24 | $11.3M | $3.0M | ||
| Q3 24 | $10.9M | $2.3M | ||
| Q2 24 | $10.7M | $2.0M | ||
| Q1 24 | $10.5M | $3.5M |
净利润FCAPRNA
| Q4 25 | $4.9M | — | ||
| Q3 25 | $4.5M | $-174.4M | ||
| Q2 25 | $3.8M | $-157.3M | ||
| Q1 25 | $3.2M | $-115.8M | ||
| Q4 24 | $3.3M | $-102.3M | ||
| Q3 24 | $2.9M | $-80.4M | ||
| Q2 24 | $2.8M | $-70.8M | ||
| Q1 24 | $3.0M | $-68.9M |
营业利润率FCAPRNA
| Q4 25 | — | — | ||
| Q3 25 | 41.8% | -1513.5% | ||
| Q2 25 | 37.2% | -4448.7% | ||
| Q1 25 | 34.2% | -8360.9% | ||
| Q4 24 | 34.8% | -4069.6% | ||
| Q3 24 | 31.5% | -4200.9% | ||
| Q2 24 | 31.1% | -4040.4% | ||
| Q1 24 | 33.0% | -2178.6% |
净利率FCAPRNA
| Q4 25 | 36.2% | — | ||
| Q3 25 | 33.8% | -1398.3% | ||
| Q2 25 | 30.4% | -4089.3% | ||
| Q1 25 | 28.3% | -7360.0% | ||
| Q4 24 | 28.8% | -3439.5% | ||
| Q3 24 | 26.5% | -3441.7% | ||
| Q2 24 | 26.5% | -3461.8% | ||
| Q1 24 | 28.1% | -1943.4% |
每股收益（稀释后）FCAPRNA
| Q4 25 | $1.45 | — | ||
| Q3 25 | $1.34 | $-1.27 | ||
| Q2 25 | $1.13 | $-1.21 | ||
| Q1 25 | $0.97 | $-0.90 | ||
| Q4 24 | $0.97 | $-0.80 | ||
| Q3 24 | $0.87 | $-0.65 | ||
| Q2 24 | $0.85 | $-0.65 | ||
| Q1 24 | $0.88 | $-0.79 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $350.2M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $137.8M | $1.9B |
| 总资产 | $1.3B | $2.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FCAPRNA
| Q4 25 | — | — | ||
| Q3 25 | — | $350.2M | ||
| Q2 25 | — | $243.9M | ||
| Q1 25 | — | $254.2M | ||
| Q4 24 | — | $219.9M | ||
| Q3 24 | — | $370.2M | ||
| Q2 24 | — | $575.8M | ||
| Q1 24 | — | $471.4M |
股东权益FCAPRNA
| Q4 25 | $137.8M | — | ||
| Q3 25 | $132.4M | $1.9B | ||
| Q2 25 | $123.2M | $1.2B | ||
| Q1 25 | $120.1M | $1.3B | ||
| Q4 24 | $114.6M | $1.4B | ||
| Q3 24 | $116.8M | $1.5B | ||
| Q2 24 | $107.8M | $1.2B | ||
| Q1 24 | $105.7M | $830.9M |
总资产FCAPRNA
| Q4 25 | $1.3B | — | ||
| Q3 25 | $1.2B | $2.1B | ||
| Q2 25 | $1.2B | $1.4B | ||
| Q1 25 | $1.2B | $1.5B | ||
| Q4 24 | $1.2B | $1.6B | ||
| Q3 24 | $1.2B | $1.6B | ||
| Q2 24 | $1.2B | $1.3B | ||
| Q1 24 | $1.2B | $951.5M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $21.3M | $-156.2M |
| 自由现金流经营现金流 - 资本支出 | $19.9M | $-156.9M |
| 自由现金流率自由现金流/营收 | 147.7% | -1257.6% |
| 资本支出强度资本支出/营收 | 10.0% | 5.7% |
| 现金转化率经营现金流/净利润 | 4.36× | — |
| 过去12个月自由现金流最近4个季度 | $35.3M | $-592.3M |
8季度趋势，按日历期对齐
经营现金流FCAPRNA
| Q4 25 | $21.3M | — | ||
| Q3 25 | $7.9M | $-156.2M | ||
| Q2 25 | $3.7M | $-199.7M | ||
| Q1 25 | $4.4M | $-124.8M | ||
| Q4 24 | $22.3M | $-99.9M | ||
| Q3 24 | $7.6M | $-65.6M | ||
| Q2 24 | $3.5M | $-65.0M | ||
| Q1 24 | $7.2M | $-70.4M |
自由现金流FCAPRNA
| Q4 25 | $19.9M | — | ||
| Q3 25 | $7.8M | $-156.9M | ||
| Q2 25 | $3.5M | $-203.0M | ||
| Q1 25 | $4.2M | $-128.6M | ||
| Q4 24 | $21.6M | $-103.8M | ||
| Q3 24 | $7.5M | $-67.3M | ||
| Q2 24 | $3.3M | $-65.5M | ||
| Q1 24 | $7.1M | $-71.3M |
自由现金流率FCAPRNA
| Q4 25 | 147.7% | — | ||
| Q3 25 | 58.6% | -1257.6% | ||
| Q2 25 | 27.8% | -5277.1% | ||
| Q1 25 | 36.5% | -8174.3% | ||
| Q4 24 | 190.7% | -3491.0% | ||
| Q3 24 | 68.6% | -2881.8% | ||
| Q2 24 | 31.2% | -3204.6% | ||
| Q1 24 | 67.2% | -2012.3% |
资本支出强度FCAPRNA
| Q4 25 | 10.0% | — | ||
| Q3 25 | 1.2% | 5.7% | ||
| Q2 25 | 2.2% | 86.9% | ||
| Q1 25 | 1.9% | 238.6% | ||
| Q4 24 | 6.3% | 131.7% | ||
| Q3 24 | 0.8% | 72.9% | ||
| Q2 24 | 1.4% | 26.0% | ||
| Q1 24 | 1.5% | 25.8% |
现金转化率FCAPRNA
| Q4 25 | 4.36× | — | ||
| Q3 25 | 1.77× | — | ||
| Q2 25 | 0.99× | — | ||
| Q1 25 | 1.36× | — | ||
| Q4 24 | 6.84× | — | ||
| Q3 24 | 2.62× | — | ||
| Q2 24 | 1.23× | — | ||
| Q1 24 | 2.45× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
